Connect with us

Hi, what are you looking for?

Investing

Minerva Neurosciences Shares Rise 25% FDA Files NDA for Roluperidone

By Chris Wack

Minerva Neurosciences, Inc. shares were up 25%, to $3.50, after the company said that the U.S. Food and Drug Administration filed its New Drug Application for roluperidone for the treatment of negative symptoms in patients with schizophrenia.

The company said the decision to file the NDA follows its request for formal dispute…

Read the full article here

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

News

Casino oyun türleri, tarih boyunca birçok değişiklik ve değişim geçirmiştir. İlk başlangıçta, M.Ö. 3000 senelerinde Çin’de çıkmış çıkan oyunlar, zaman içinde farklı medeniyetlerde çeşitli...

Uncategorized

Blogs 40 flaming lines slot free spins – Heritage of Dead for the Cellular Legacy out of Deceased™ Slot What is the gambling variety...

Uncategorized

Content Freispiele via das ersten Einzahlung Genau so wie darf selbst 70 Freispiele ohne Einzahlung bedingen? Maklercourtage je Bestandskunden Nutzen Eltern nachfolgende Freispiele Andere...

News

Artificial Intelligence (AI) is changing the casino field by streamlining processes, enhancing customer experiences, and refining protection measures. In 2023, a report by Deloitte...